BIOS
BioPlus Acquisition Corp. Class A Ordinary Shares
BIOS
BIOS
Delisted
BIOS was delisted on the 6th of October, 2023.
56 hedge funds and large institutions have $173M invested in BioPlus Acquisition Corp. Class A Ordinary Shares in 2022 Q1 according to their latest regulatory filings, with 56 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
56
Holders Change
+56
Holders Change %
–
% of All Funds
0.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
56
Increased
–
Reduced
–
Closed
–
Calls
$99K
Puts
–
Net Calls
+$99K
Net Calls Change
+$99K
Top Buyers
| 1 |
SCM
1
Saba Capital Management
New York
|
$15.2M |
| 2 |
HCM
2
Highbridge Capital Management
New York
|
$11.7M |
| 3 |
LA
3
Linden Advisors
New York
|
$9.88M |
| 4 |
4
Millennium Management
New York
|
$9.78M |
| 5 |
5
Goldman Sachs
New York
|
$8.15M |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BFM
51
Boothbay Fund Management
New York
| $205K | 20,733 | +20,733 | New |
|
|
PP
52
Paloma Partners
Greenwich,
Connecticut
| $198K | 20,000 | +20,000 | New |
|
|
SSA
53
Schonfeld Strategic Advisors
New York
| $99K | 10,000 | +10,000 | New |
|
54
Royal Bank of Canada
Toronto,
Ontario, Canada
| $22K | 2,200 | +2,200 | New |
|
|
S
55
SignatureFD
Atlanta,
Georgia
| $2K | 67 | +67 | New |
|
|
ASM
56
ATW SPAC Management
New York
| $205 | 20,733 | +20,733 | New |
|
|
CFGS
57
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|